✦ LIBER ✦
Continued use of goserelin to achieve ovarian function suppression in combination with a further aromatase inhibitor (exemestane) following prior treatment with anastrozole and/or tamoxifen in premenopausal women with oestrogen receptor positive advanced breast cancer
✍ Scribed by A. Agrawal; Robertson; L. Winterbottom; K. Cheung
- Book ID
- 118624707
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 266 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.